Gladstone Institutional Advisory’s CME Group CME Stock Holding History

Gladstone Institutional Advisory’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16M	Buy	9,773 +63	+0.6%	+$17.4K	0.07%	277
2026 Q1	$2.87M	Buy	9,710 +403	+4%	+$120K	0.11%	202
2025 Q4	$2.54M	Buy	9,307 +1,878	+25%	+$510K	0.1%	223
2025 Q3	$2.01M	Buy	+7,429	New	+$2.02M	0.08%	244
2024 Q1	–	Sell	-3,945	Closed	-$831K	–	653
2023 Q4	$831K	Buy	+3,945	New	+$842K	0.05%	321
2023 Q3	–	Sell	-1,387	Closed	-$257K	–	629
2023 Q2	$257K	Sell	1,387 -3,013	-68%	-$557K	0.02%	546
2023 Q1	$843K	Sell	4,400 -9,013	-67%	-$1.63M	0.05%	319
2022 Q4	$2.26M	Buy	13,413 +2,796	+26%	+$486K	0.16%	181
2022 Q3	$1.88M	Buy	+10,617	New	+$2.1M	0.15%	177

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Gladstone Institutional Advisory's CME Position: Q2 2026 in Review

Gladstone Institutional Advisory increased its CME Group (CME) stake by 0.65% in Q2 2026, buying an estimated $17.4K and bringing the position to 9,773 shares worth $2.16M. The position accounts for 0.07% of the portfolio, ranked #277.

Gladstone Institutional Advisory first reported a position in CME in Q3 2022 and has held it in 9 quarters since. The position peaked at $2.87M in Q1 2026. 1,706 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Gladstone Institutional Advisory held 9,773 shares of CME Group worth $2.16M as of Q2 2026.
Gladstone Institutional Advisory bought 63 CME Group shares in Q2 2026, an estimated $17.4K.
CME Group made up 0.07% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #277 holding.
Gladstone Institutional Advisory first reported a position in CME Group in Q3 2022 and has held it in 9 quarters since.
Gladstone Institutional Advisory's CME Group position peaked at $2.87M in Q1 2026.
1,706 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.